BNP Paribas Financial Markets
DOVA

BNP Paribas Financial Markets’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

BNP Paribas Financial Markets’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,707
Closed -$47.7K – 4572
2019
Q3 		$47.7K Buy
1,707
+403
+31% +$6.53K ﹤0.01% 3500
2019
Q2 		$18.4K Sell
1,304
-1,143
-47% -$10.9K ﹤0.01% 3927
2019
Q1 		$21.8K Buy
+2,447
New +$19.9K ﹤0.01% 3884
2018
Q4 		– Sell
-458
Closed -$9.6K – 4498
2018
Q3 		$9.6K Hold
458
– – ﹤0.01% 3753
2018
Q2 		$13.7K Sell
458
-1,296
-74% -$35.3K ﹤0.01% 3651
2018
Q1 		$47.6K Buy
1,754
+579
+49% +$17.3K ﹤0.01% 3591
2017
Q4 		$33.8K Buy
+1,175
New +$32.2K ﹤0.01% 3840

BNP Paribas Financial Markets's DOVA Position: Q4 2019 in Review

BNP Paribas Financial Markets sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 1,707 shares — an estimated $47.7K sold.

BNP Paribas Financial Markets first reported a position in DOVA in Q4 2017 and held it in 7 quarters. The position peaked at $47.7K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • BNP Paribas Financial Markets reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,707 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $47.7K.
  • BNP Paribas Financial Markets first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 7 quarters.
  • BNP Paribas Financial Markets's Dova Pharmaceuticals, Inc. Common Stock position peaked at $47.7K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.